2 options
Pay to delay : are patent settlements that delay generic drug market entry anticompetitive? : hearing before the Subcommittee on Courts and Competition Policy of the Committee on the Judiciary, House of Representatives, One Hundred Eleventh Congress, first session, June 3, 2009.
- Format:
- Book
- Government document
- Author/Creator:
- United States. Congress. House. Committee on the Judiciary. Subcommittee on Courts and Competition Policy
- Language:
- English
- Subjects (All):
- Pharmaceutical industry--United States.
- Pharmaceutical industry.
- Competition.
- Drugs--Prices--United States.
- Drugs.
- Drugs--United States--Patents.
- Drugs--Law and legislation--United States.
- Patent laws and legislation--United States.
- Patent laws and legislation.
- Drugs--Law and legislation.
- Drugs--Prices.
- United States.
- Genre:
- patents.
- Patents
- Patents.
- Physical Description:
- 1 online resource (iii, 180 pages) : illustrations
- Other Title:
- Are patent settlements that delay generic drug market entry anticompetitive?
- Place of Publication:
- Washington : U.S. G.P.O., 2010.
- Notes:
- Includes bibliographical references.
- Other Format:
- Print version: United States. Congress. House. Committee on the Judiciary. Subcommittee on Courts and Competition Policy. Pay to delay : are patent settlements that delay generic drug market entry anticompetitive
- Microfiche: United States. Congress. House. Committee on the Judiciary. Subcommittee on Courts and Competition Policy. Pay to delay : are patent settlements that delay generic drug market entry anticompetitive
- OCLC:
- 672394995
- Access Restriction:
- Use copy Restrictions unspecified
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.